✦ LIBER ✦

P-770 Topotecan improves performance status (PS) and clinicalresponse in patients with relapsed small cell lung cancer (SCLC) and poor PS at baseline

✍ Scribed by Huber, R.; Lilenbaum, R.; Treat, J.; Masters, G.; Kaubitzsch, S.; Lane, S.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Topotecan Therapy in Patients with Relap

✍ Rogerio C. Lilenbaum; Rudolf M. Huber; Joseph Treat; Gregory Masters; Sabine Kau 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 138 KB

P-579 Topotecan in the treatment of rela

✍ Treat, Joseph; Huang, Chao Hui 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Can long-term survival be improved in pa

✍ Bleehen, NM; Girling, DJ; Gregor, A; Leonard, RCF; Machin, D; McKenzie, CG; Morg 📂 Article 📅 1994 🏛 Nature Publishing Group 🌐 English ⚖ 558 KB

Sequential chemotherapy with carboplatin

✍ Edelman, M.J; Gandara, D.R; Lau, D; Lara, P; Lauder, I 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 209 KB

787 Performance status (PS) and quality

✍ Radosavljević, D.; Jelić, S.; Radulović, S.; Popov, I.; Nikolić-Tomašević, Z.; B 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 141 KB

P-327 Can performance status (PS) be det

✍ Gralla, R.; Hollen, P.; Kuruvilla, P.; Meharchand, J.; Solow, H.; Leighl, N.; Ch 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 268 KB